453 related articles for article (PubMed ID: 34753140)
1. The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.
Wee HN; Liu JJ; Ching J; Kovalik JP; Lim SC
Am J Nephrol; 2021; 52(10-11):771-787. PubMed ID: 34753140
[TBL] [Abstract][Full Text] [Related]
2. The Role of Tryptophan Metabolism in the Occurrence and Progression of Acute and Chronic Kidney Diseases.
Hui Y; Zhao J; Yu Z; Wang Y; Qin Y; Zhang Y; Xing Y; Han M; Wang A; Guo S; Yuan J; Zhao Y; Ning X; Sun S
Mol Nutr Food Res; 2023 Nov; 67(21):e2300218. PubMed ID: 37691068
[TBL] [Abstract][Full Text] [Related]
3. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.
Zhang J; Liu Y; Zhi X; Xu L; Tao J; Cui D; Liu TF
Inflamm Res; 2024 Jun; 73(6):979-996. PubMed ID: 38592457
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
Zhang X; Agborbesong E; Li X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
[TBL] [Abstract][Full Text] [Related]
6. The kynurenine pathway and neurodegenerative disease.
Maddison DC; Giorgini F
Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes.
Sheipouri D; Grant R; Bustamante S; Lovejoy D; Guillemin GJ; Braidy N
J Cell Biochem; 2015 Jun; 116(6):903-22. PubMed ID: 25639585
[TBL] [Abstract][Full Text] [Related]
8. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
Ciapała K; Mika J; Rojewska E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
[TBL] [Abstract][Full Text] [Related]
9. The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.
Curran CS; Kopp JB
J Transl Med; 2023 Oct; 21(1):706. PubMed ID: 37814337
[TBL] [Abstract][Full Text] [Related]
10. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine Pathway-An Underestimated Factor Modulating Innate Immunity in Sepsis-Induced Acute Kidney Injury?
Krupa A; Krupa MM; Pawlak K
Cells; 2022 Aug; 11(16):. PubMed ID: 36010680
[TBL] [Abstract][Full Text] [Related]
12. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
Clària J; Moreau R; Fenaille F; Amorós A; Junot C; Gronbaek H; Coenraad MJ; Pruvost A; Ghettas A; Chu-Van E; López-Vicario C; Oettl K; Caraceni P; Alessandria C; Trebicka J; Pavesi M; Deulofeu C; Albillos A; Gustot T; Welzel TM; Fernández J; Stauber RE; Saliba F; Butin N; Colsch B; Moreno C; Durand F; Nevens F; Bañares R; Benten D; Ginès P; Gerbes A; Jalan R; Angeli P; Bernardi M; Arroyo V;
Hepatology; 2019 Apr; 69(4):1686-1701. PubMed ID: 30521097
[TBL] [Abstract][Full Text] [Related]
13. Acute Kidney Injury to Chronic Kidney Disease Transition.
Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
[TBL] [Abstract][Full Text] [Related]
14. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations.
Muneer A
Clin Psychopharmacol Neurosci; 2020 Nov; 18(4):507-526. PubMed ID: 33124585
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction and the AKI-to-CKD transition.
Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
[TBL] [Abstract][Full Text] [Related]
17. The path to chronic kidney disease following acute kidney injury: a neonatal perspective.
Chaturvedi S; Ng KH; Mammen C
Pediatr Nephrol; 2017 Feb; 32(2):227-241. PubMed ID: 26809804
[TBL] [Abstract][Full Text] [Related]
18. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
19. Understanding the roles of the kynurenine pathway in multiple sclerosis progression.
Lim CK; Brew BJ; Sundaram G; Guillemin GJ
Int J Tryptophan Res; 2010; 3():157-67. PubMed ID: 22084596
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
